Biomarkers in fetal alcohol syndrome

Biomarkers and Genomic Medicine

Volumn 6, Issue 1, 2014, Pages 12-22

  Chabenne, Anthony ^a   Moon, Carrolyn ^a   Ojo, Comfort ^a   Khogali, Azza ^a   Nepal, Bal ^b   Sharma, Sushil ^a  

^a SAINT JAMES SCHOOL OF MEDICINE   (Anguilla)

^b UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Biomarkers; Early diagnosis; Fetal alcohol syndrome; Prognosis

Indexed keywords

ADENYLATE CYCLASE; ALCOHOL; BIOLOGICAL MARKER; BRAIN DERIVED NEUROTROPHIC FACTOR; CHOLINE; COCAINE; CREATINE; DNA; FATTY ACID ESTER; GAMMA GLUTAMYLTRANSFERASE; GLUTAMIC ACID; GLUTATHIONE; HISTONE; HOMOCYSTEINE; INOSITOL; LEPTIN; METHIONINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NICOTINE; PHOSPHATIDYLETHANOLAMINE; SOMATOMEDIN; SOMATOSTATIN; TAURINE;

ALCOHOL CONSUMPTION; AUTISM; BODY MASS; BRAIN CORTEX; BRAIN SIZE; DEPRESSION; DIFFERENTIAL DIAGNOSIS; DNA METHYLATION; DRINKING BEHAVIOR; FETAL ALCOHOL SYNDROME; FETUS; HEREDITY; HISTONE METHYLATION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MATERNAL BEHAVIOR; MEAN CORPUSCULAR VOLUME; MECONIUM; NEUROIMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PREGNANCY; PRENATAL EXPOSURE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SUDDEN INFANT DEATH SYNDROME;

EID: 84897963230     PISSN: 22140247     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bgm.2014.01.002     Document Type: Review

References (62)

1. Lange S., Shield K., Rehm J., et al. Prevalence of fetal alcohol spectrum disorders in child care settings: a meta-analysis. Pediatrics 2013, 132:980-995.
2. Memo L., Gnoato E., Caminiti S., et al. Fetal alcohol spectrum disorders and fetal alcohol syndrome: the state of the art and new diagnostic tools. Early Hum Dev 2013, 89(suppl 1):S40-S43.
3. Pulsifer M.B. The neuropsychology of mental retardation. J Int Neuropsychol Soc 1996, 2:159-176.
4. Hoyme H.E., May P.A., Kalberg W.O., et al. A practical clinical approach to diagnosis of fetal alcohol spectrum disorders: clarification of the 1996 Institute of Medicine Criteria. Pediatrics 2005, 115:39-47.
5. Vaurio L., Crocker N., Mattson S.N. Fetal alcohol spectrum disorders. The Handbook of Pediatric Neuropsychology 2010, 877-886. Springer Publishing Company, New York. A.S. Davis (Ed.).
6. Vagnarelli F., Palmi I., García-Algar O., et al. A survey of Italian and Spanish neonatologists and paediatricians regarding awareness of the diagnosis of FAS and FASD and maternal ethanol use during pregnancy. BMC Pediatr 2011, 11:51.
7. Mattson S.N., Riley E.P. The quest for a neurobehavioral profile of heavy prenatal alcohol exposure. Alcohol Res Health 2011, 34:51-55.
8. Cook J.D. Biochemical markers of alcohol use in pregnant women. Clin Biochem 2003, 36:9-19.
9. Falk D., Yi H.Y., Hiller-Sturmhöfel S. An epidemiologic analysis of co-occurring alcohol and drug use and disorders: findings from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). Alcohol Res Health 2008, 31:100-110.
10. Falk D., Yi H.Y., Hiller-Sturmhöfel S. An epidemiologic analysis of co-occurring alcohol and tobacco use and disorders: findings from the National Epidemiologic Survey on Alcohol and Related Conditions. Alcohol Res Health 2006, 29:162-171.
11. Sharma S., Ebadi M. SPECT neuroimaging in translational research of CNS disorders. Neurochem Int 2008, 52:352-362.
12. McCance E.F., Price L.H., Kosten T.R., et al. Cocaethylene: pharmacology, physiology and behavioral effects in humans. J Pharmacol Exp Ther 1995, 274:215-223.
13. Pennings E.J., Leccese A.P., Wolff F.A. Effects of concurrent use of alcohol and cocaine. Addiction 2002, 97:773-783.
14. Strimbu K., Tavel J.A. What is a biomarker?. Curr Opin HIV AIDS 2010, 5:463-466.
15. Peterson K. Biomarkers for Alcohol Use and Abuse (A Summary of Alcohol Use and Abuse) 2004, Monograph, National Institute of Alcohol Abuse and Alcoholism.
16. Anttila P., Jarvi K., Latvala J., et al. Method-dependent characteristics of carbohydrate-deficient transferrin measurements in the follow-up of alcoholics. Alcohol Alcohol 2004, 39:59-63.
17. Javors M.A., Johnson B.A. Current status of carbohydrate-deficient transferrin, total serum sialic acid, sialic acid index of apolipoprotein J and serum beta-hexosaminidase as markers for alcohol consumption. Addiction 2003, 98(suppl 2):45-50.
18. Wurst F.M., Alexson S., Wolfersdorf M., et al. Concentration of fatty acid ethyl esters in hair of alcoholics: comparison to other biological state markers and self-reported ethanol intake. Alcohol Alcohol 2004, 39:33-38.
19. Hoffman P.L., Glanz J., Tabakoff B., et al. Platelet adenylyl cyclase activity as a state or trait marker in alcohol dependence: results of the WHO/ISBRA study on state and trait markers of alcohol use and dependence. Alcohol Clin Exp Res 2002, 26:1078-1087.
20. Ratsma J.E., Van Der Stelt O., Gunning W.B. Neurochemical markers of alcoholism vulnerability in humans. Alcohol Alcohol 2002, 37:522-533.
21. Zalewska-Kaszubska J., Czarnecka E. Deficit in beta-endorphin peptide and tendency to alcohol abuse. Peptides 2005, 26:701-705.
22. Bates E.A. A potential molecular target for morphological defects of fetal alcohol syndrome: Kir2.1. Curr Opin Genet Dev 2013, 23:324-329.
23. Downing C., Flink S., Florez-McClure M.L., et al. Gene expression changes in C57BL/6J and DBA/2J mice following prenatal alcohol exposure. Alcohol Clin Exp Res 2012, 36:1519-1529.
24. Yang Y., Phillips O.R., Kan E., et al. Callosal thickness reductions relate to facial dysmorphology in fetal alcohol spectrum disorders. Alcohol Clin Exp Res 2012, 36:798-806.
25. Yang Y., Roussotte F., Kan E., et al. Abnormal cortical thickness alterations in fetal alcohol spectrum disorders and their relationships with facial dysmorphology. Cereb Cortex 2012, 22:1170-1179.
26. Dursun I., Jakubowska-Doǧru E., van der List D., et al. Effects of early postnatal exposure to ethanol on retinal ganglion cell morphology and numbers of neurons in the dorsolateral geniculate in mice. Alcohol Clin Exp Res 2011, 35:2063-2074.
27. VandeVoort C.A., Hill D.L., Chaffin C.L., et al. Ethanol, acetaldehyde, and estradiol affect growth and differentiation of rhesus monkey embryonic stem cells. Alcohol Clin Exp Res 2011, 35:1534-1540.
28. Godin E.A., Dehart D.B., Parnell S.E., et al. Ventromedian forebrain dysgenesis follows early prenatal ethanol exposure in mice. Neurotoxicol Teratol 2011, 33:231-239.
29. Van Horn J.D., Toga A.W. Multisite neuroimaging trials. Curr Opin Neurol 2009, 22:370-378.
30. Hao H.N., Parker G.C., Zhao J., et al. Differential responses of human neural and hematopoietic stem cells to ethanol exposure. J Hematother Stem Cell Res 2003, 12:389-399.
31. Lee I.J., Soh Y., Song B.J. Molecular characterization of fetal alcohol syndrome using mRNA differential display. Biochem Biophys Res Commun 1997, 240:309-313.
32. Baraona E., Gentry R.T., Lieber C.S. Bioavailability of alcohol: role of gastric metabolism and its interaction with other drugs. Dig Disord 1994, 12:351-367.
33. Fraser A.G. Is there an interaction between H2-antagonists and alcohol?. Drug Metabol Drug Interact 1998, 14:123-145.
34. Gentry R.T., Baraona E., Amir I., et al. Mechanism of the aspirin-induced rise in blood alcohol levels. Life Sci 1999, 65:2505-2512.
35. Bonthius D.J., West J.R. Blood alcohol concentration and microencephaly: a dose-response study in the neonatal rat. Teratology 1988, 37:223-231.
36. Bonthius D.J., West J.R. Alcohol-induced neuronal loss in developing rats: increased brain damage with binge exposure. Alcohol Clin Exp Res 1990, 14:107-118.
37. Johnson R.D., Horowitz M., Maddox A.F., et al. Cigarette smoking and rate of gastric emptying: effect on alcohol absorption. BMJ 1991, 302:20-23.
38. Gilbertson R.J., Barron S. Neonatal ethanol and nicotine exposure causes locomotor activity changes in preweaning animals. Pharmacol Biochem Behav 2005, 81:54-64.
39. Parnell S.E., O'Leary-Moore S.K., Godin E.A., et al. Magnetic resonance microscopy defines ethanol-induced brain abnormalities in prenatal mice: effects of acute insult on gestational day 8. Alcohol Clin Exp Res 2009, 33:1001-1011.
40. Ismail S., Buckley S., Budacki R., et al. Screening, diagnosing and prevention of fetal alcohol syndrome: is this syndrome treatable?. Dev Neurosci 2010, 32:91-100.
41. Roehsig M., de Paula D.M., Moura S., et al. Determination of eight fatty acid ethyl esters in meconium samples by headspace solid-phase microextraction and gas chromatography-mass spectrometry. J Sep Sci 2010, 33:2115-2122.
42. Dutta S., Turner D., Singh R., et al. Fetal alcohol syndrome (FAS) in C57BL/6 mice detected through proteomics screening of the amniotic fluid. Birth Defects Res A Clin Mol Teratol 2008, 82:177-186.
43. Través C., Coll O., Cararach V., et al. Clinical approach to intestinal maturation in neonates prenatally exposed to alcohol. Alcohol Alcohol 2007, 42:407-412.
44. Barr A.M., Hofmann C.E., Phillips A.G., et al. Prenatal ethanol exposure in rats decreases levels of complexin proteins in the frontal cortex. Alcohol Clin Exp Res 2005, 29:1915-1920.
45. Peng Y., Yang P.H., Guo Y., et al. Catalase and peroxiredoxin 5 protect Xenopus embryos against alcohol-induced ocular anomalies. Invest Ophthalmol Vis Sci 2004, 45:23-29.
46. Miller P.M., Ornstein S.M., Nietert P.J., et al. Self-report and biomarker alcohol screening by primary care physicians: the need to translate research into guidelines and practice. Alcohol Alcohol 2004, 39(4):325-328.
47. Natekar A., Motok I., Walasek P., et al. Cocaethylene as a biomarker to predict heavy alcohol exposure among cocaine users. J Popul Ther Clin Pharmacol 2010, 19:e466-e472.
48. Joya X., Friguls B., Ortigosa S., et al. Determination of maternal-fetal biomarkers of prenatal exposure to ethanol: a review. J Pharm Biomed Anal 2012, 69:209-222.
49. Kane C.J., Smith S.M., Miranda R.C., et al. Proceedings of the 2010 annual meeting of the Fetal Alcohol Spectrum Disorders Study Group. Alcohol 2012, 46:107-114.
50. Aros S., Mills J.L., Iñiguez G., et al. Effects of prenatal ethanol exposure on postnatal growth and the insulin-like growth factor axis. Horm Res Paediatr 2011, 75:166-173.
51. Zhou F.C., Balaraman Y., Teng M., et al. Alcohol alters DNA methylation patterns and inhibits neural stem cell differentiation. Alcohol Clin Exp Res 2011, 35:735-746.
52. Yon J.M., Lin C., Oh K.W., et al. Emodin prevents ethanol-induced developmental anomalies in cultured mouse fetus through multiple activities. Birth Defects Res B Dev Reprod Toxicol 2013, 98:268-275.
53. Bakhireva L.N., Savich R.D., Raisch D.W., et al. The feasibility and cost of neonatal screening for prenatal alcohol exposure by measuring phosphatidylethanol in dried blood spots. Alcohol Clin Exp Res 2013, 37:1008-1015.
54. Stewart S.H., Law T.L., Randall P.K., et al. Phosphatidylethanol and alcohol consumption in reproductive age women. Alcohol Clin Exp Res 2012, 34:488-492.
55. Leigland L.A., Ford M.M., Lerch J.P., et al. The influence of fetal ethanol exposure on subsequent development of the cerebral cortex as revealed by magnetic resonance imaging. Alcohol Clin Exp Res 2013, 37:924-932.
56. Ikonomidou C., Bittigau P., Ishimaru M.J., et al. Ethanol-induced apoptotic neurodegeneration and fetal alcohol syndrome. Science 2000, 287:1056-1060.
57. Coleman L.G., Oguz I., Lee J., et al. Postnatal day 7 ethanol treatment causes persistent reductions in adult mouse brain volume and cortical neurons with sex specific effects on neurogenesis. Alcohol 2012, 46:603-612.
58. May P.A., Gossage J.P., Kalberg W.O., et al. Prevalence and epidemiologic characteristics of FASD from various research methods with an emphasis on recent in-school studies. Dev Disabil Res Rev 2009, 15:176-192.
59. Flynn H.A., Chermack S.T. Prenatal alcohol use: the role of lifetime problems with alcohol, drugs, depression, and violence. J Stud Alcohol Drugs 2008, 69:500-509.
60. Henderson K.M., Clark C.J., Lewis T.T., et al. Psychosocial distress and stroke risk in older adults. Stroke 2013, 44:367-372.
61. Rubio J.M., Olfson M., Villegas L., et al. Quality of life following remission of mental disorders: findings from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry 2013, 74:445-450.
62. Faisal S., Patel A., Mattison C., et al. Effect of diet on, serotonergic neurotransmission in depression. Neurochem Int 2013, 62:324-329.